aluates Reports

$ 0.0

Automative

Global Targeted Radiotherapy Drug Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-2U15903

Global Targeted Radiotherapy Drug Market Research Report 2023

BUY CHAPTERS

Global Targeted Radiotherapy Drug Market Research Report 2025

Code: QYRE-Auto-2U15903

Report

May 2025

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Bayer

Endocyte

Progenics Pharmaceuticals

Jubilant Radiopharma

Curium

Nucleus RadioPharma

Fermi Energia

Targeted Radiotherapy Drug Market Size

The global market for Targeted Radiotherapy Drug was valued at US$ 6568 million in the year 2024 and is projected to reach a revised size of US$ 9692 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Targeted Radiotherapy Drug Market

Targeted radiotherapy is a medical treatment designed to direct radioactive isotopes to specific types of tumor cells or tumor markers, allowing for precise tumor treatment. These drugs offer a promising treatment for some malignant tumors, especially those that are advanced or difficult to surgically remove. As technology develops, treatment effects, as well as patient survival and quality of life after treatment, can be better monitored and evaluated. The development trend of targeted radiotherapy drugs emphasizes precise treatment, personalized treatment and comprehensive treatment methods. This will hopefully provide more effective cancer treatments in the future and improve patient survival and quality of life.

This report aims to provide a comprehensive presentation of the global market for Targeted Radiotherapy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Radiotherapy Drug.

The Targeted Radiotherapy Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Targeted Radiotherapy Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Targeted Radiotherapy Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Targeted Radiotherapy Drug Market Report

Report Metric	Details
Report Name	Targeted Radiotherapy Drug Market
Accounted market size in year	US$ 6568 million
Forecasted market size in 2031	US$ 9692 million
CAGR	5.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Radioactive Iodine Therapeutic Drugs Radioactive Antibody Therapeutic Drugs Others
Segment by Application	General Hospital Specialty Hospital
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Bayer, Endocyte, Progenics Pharmaceuticals, Jubilant Radiopharma, Curium, Fermi Energia, Nucleus RadioPharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Radiotherapy Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Targeted Radiotherapy Drug Market growing?

Ans: The Targeted Radiotherapy Drug Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Targeted Radiotherapy Drug Market size in 2031?

Ans: The Targeted Radiotherapy Drug Market size in 2031 will be US$ 9692 million.

Who are the main players in the Targeted Radiotherapy Drug Market report?

Ans: The main players in the Targeted Radiotherapy Drug Market are Novartis, Bayer, Endocyte, Progenics Pharmaceuticals, Jubilant Radiopharma, Curium, Fermi Energia, Nucleus RadioPharma

What are the Application segmentation covered in the Targeted Radiotherapy Drug Market report?

Ans: The Applications covered in the Targeted Radiotherapy Drug Market report are General Hospital, Specialty Hospital

What are the Type segmentation covered in the Targeted Radiotherapy Drug Market report?

Ans: The Types covered in the Targeted Radiotherapy Drug Market report are Radioactive Iodine Therapeutic Drugs, Radioactive Antibody Therapeutic Drugs, Others

Recommended Reports

Radiotherapy Technologies

Targeted Therapies

Radiopharmaceuticals

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Targeted Radiotherapy Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Radioactive Iodine Therapeutic Drugs

1.2.3 Radioactive Antibody Therapeutic Drugs

1.2.4 Others

1.3 Market by Application

1.3.1 Global Targeted Radiotherapy Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 General Hospital

1.3.3 Specialty Hospital

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Targeted Radiotherapy Drug Market Perspective (2020-2031)

2.2 Global Targeted Radiotherapy Drug Growth Trends by Region

2.2.1 Global Targeted Radiotherapy Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Targeted Radiotherapy Drug Historic Market Size by Region (2020-2025)

2.2.3 Targeted Radiotherapy Drug Forecasted Market Size by Region (2026-2031)

2.3 Targeted Radiotherapy Drug Market Dynamics

2.3.1 Targeted Radiotherapy Drug Industry Trends

2.3.2 Targeted Radiotherapy Drug Market Drivers

2.3.3 Targeted Radiotherapy Drug Market Challenges

2.3.4 Targeted Radiotherapy Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Targeted Radiotherapy Drug Players by Revenue

3.1.1 Global Top Targeted Radiotherapy Drug Players by Revenue (2020-2025)

3.1.2 Global Targeted Radiotherapy Drug Revenue Market Share by Players (2020-2025)

3.2 Global Targeted Radiotherapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Targeted Radiotherapy Drug Revenue

3.4 Global Targeted Radiotherapy Drug Market Concentration Ratio

3.4.1 Global Targeted Radiotherapy Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Targeted Radiotherapy Drug Revenue in 2024

3.5 Global Key Players of Targeted Radiotherapy Drug Head office and Area Served

3.6 Global Key Players of Targeted Radiotherapy Drug, Product and Application

3.7 Global Key Players of Targeted Radiotherapy Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Targeted Radiotherapy Drug Breakdown Data by Type

4.1 Global Targeted Radiotherapy Drug Historic Market Size by Type (2020-2025)

4.2 Global Targeted Radiotherapy Drug Forecasted Market Size by Type (2026-2031)

5 Targeted Radiotherapy Drug Breakdown Data by Application

5.1 Global Targeted Radiotherapy Drug Historic Market Size by Application (2020-2025)

5.2 Global Targeted Radiotherapy Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Targeted Radiotherapy Drug Market Size (2020-2031)

6.2 North America Targeted Radiotherapy Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Targeted Radiotherapy Drug Market Size by Country (2020-2025)

6.4 North America Targeted Radiotherapy Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Targeted Radiotherapy Drug Market Size (2020-2031)

7.2 Europe Targeted Radiotherapy Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Targeted Radiotherapy Drug Market Size by Country (2020-2025)

7.4 Europe Targeted Radiotherapy Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Targeted Radiotherapy Drug Market Size (2020-2031)

8.2 Asia-Pacific Targeted Radiotherapy Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Targeted Radiotherapy Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Targeted Radiotherapy Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Targeted Radiotherapy Drug Market Size (2020-2031)

9.2 Latin America Targeted Radiotherapy Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Targeted Radiotherapy Drug Market Size by Country (2020-2025)

9.4 Latin America Targeted Radiotherapy Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Targeted Radiotherapy Drug Market Size (2020-2031)

10.2 Middle East & Africa Targeted Radiotherapy Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Targeted Radiotherapy Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Targeted Radiotherapy Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Targeted Radiotherapy Drug Introduction

11.1.4 Novartis Revenue in Targeted Radiotherapy Drug Business (2020-2025)

11.1.5 Novartis Recent Development

11.2 Bayer

11.2.1 Bayer Company Details

11.2.2 Bayer Business Overview

11.2.3 Bayer Targeted Radiotherapy Drug Introduction

11.2.4 Bayer Revenue in Targeted Radiotherapy Drug Business (2020-2025)

11.2.5 Bayer Recent Development

11.3 Endocyte

11.3.1 Endocyte Company Details

11.3.2 Endocyte Business Overview

11.3.3 Endocyte Targeted Radiotherapy Drug Introduction

11.3.4 Endocyte Revenue in Targeted Radiotherapy Drug Business (2020-2025)

11.3.5 Endocyte Recent Development

11.4 Progenics Pharmaceuticals

11.4.1 Progenics Pharmaceuticals Company Details

11.4.2 Progenics Pharmaceuticals Business Overview

11.4.3 Progenics Pharmaceuticals Targeted Radiotherapy Drug Introduction

11.4.4 Progenics Pharmaceuticals Revenue in Targeted Radiotherapy Drug Business (2020-2025)

11.4.5 Progenics Pharmaceuticals Recent Development

11.5 Jubilant Radiopharma

11.5.1 Jubilant Radiopharma Company Details

11.5.2 Jubilant Radiopharma Business Overview

11.5.3 Jubilant Radiopharma Targeted Radiotherapy Drug Introduction

11.5.4 Jubilant Radiopharma Revenue in Targeted Radiotherapy Drug Business (2020-2025)

11.5.5 Jubilant Radiopharma Recent Development

11.6 Curium

11.6.1 Curium Company Details

11.6.2 Curium Business Overview

11.6.3 Curium Targeted Radiotherapy Drug Introduction

11.6.4 Curium Revenue in Targeted Radiotherapy Drug Business (2020-2025)

11.6.5 Curium Recent Development

11.7 Fermi Energia

11.7.1 Fermi Energia Company Details

11.7.2 Fermi Energia Business Overview

11.7.3 Fermi Energia Targeted Radiotherapy Drug Introduction

11.7.4 Fermi Energia Revenue in Targeted Radiotherapy Drug Business (2020-2025)

11.7.5 Fermi Energia Recent Development

11.8 Nucleus RadioPharma

11.8.1 Nucleus RadioPharma Company Details

11.8.2 Nucleus RadioPharma Business Overview

11.8.3 Nucleus RadioPharma Targeted Radiotherapy Drug Introduction

11.8.4 Nucleus RadioPharma Revenue in Targeted Radiotherapy Drug Business (2020-2025)

11.8.5 Nucleus RadioPharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Bayer

Endocyte

Progenics Pharmaceuticals

Jubilant Radiopharma

Curium

Nucleus RadioPharma

Fermi Energia

List of Tables

Table 1. Global Targeted Radiotherapy Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Radioactive Iodine Therapeutic Drugs

Table 3. Key Players of Radioactive Antibody Therapeutic Drugs

Table 4. Key Players of Others

Table 5. Global Targeted Radiotherapy Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Targeted Radiotherapy Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Targeted Radiotherapy Drug Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Targeted Radiotherapy Drug Market Share by Region (2020-2025)

Table 9. Global Targeted Radiotherapy Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Targeted Radiotherapy Drug Market Share by Region (2026-2031)

Table 11. Targeted Radiotherapy Drug Market Trends

Table 12. Targeted Radiotherapy Drug Market Drivers

Table 13. Targeted Radiotherapy Drug Market Challenges

Table 14. Targeted Radiotherapy Drug Market Restraints

Table 15. Global Targeted Radiotherapy Drug Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Targeted Radiotherapy Drug Market Share by Players (2020-2025)

Table 17. Global Top Targeted Radiotherapy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radiotherapy Drug as of 2024)

Table 18. Ranking of Global Top Targeted Radiotherapy Drug Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Targeted Radiotherapy Drug Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Targeted Radiotherapy Drug, Headquarters and Area Served

Table 21. Global Key Players of Targeted Radiotherapy Drug, Product and Application

Table 22. Global Key Players of Targeted Radiotherapy Drug, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Targeted Radiotherapy Drug Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Targeted Radiotherapy Drug Revenue Market Share by Type (2020-2025)

Table 26. Global Targeted Radiotherapy Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Targeted Radiotherapy Drug Revenue Market Share by Type (2026-2031)

Table 28. Global Targeted Radiotherapy Drug Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Targeted Radiotherapy Drug Revenue Market Share by Application (2020-2025)

Table 30. Global Targeted Radiotherapy Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Targeted Radiotherapy Drug Revenue Market Share by Application (2026-2031)

Table 32. North America Targeted Radiotherapy Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Targeted Radiotherapy Drug Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Targeted Radiotherapy Drug Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Targeted Radiotherapy Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Targeted Radiotherapy Drug Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Targeted Radiotherapy Drug Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Targeted Radiotherapy Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Targeted Radiotherapy Drug Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Targeted Radiotherapy Drug Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Targeted Radiotherapy Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Targeted Radiotherapy Drug Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Targeted Radiotherapy Drug Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Targeted Radiotherapy Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Targeted Radiotherapy Drug Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Targeted Radiotherapy Drug Market Size by Country (2026-2031) & (US$ Million)

Table 47. Novartis Company Details

Table 48. Novartis Business Overview

Table 49. Novartis Targeted Radiotherapy Drug Product

Table 50. Novartis Revenue in Targeted Radiotherapy Drug Business (2020-2025) & (US$ Million)

Table 51. Novartis Recent Development

Table 52. Bayer Company Details

Table 53. Bayer Business Overview

Table 54. Bayer Targeted Radiotherapy Drug Product

Table 55. Bayer Revenue in Targeted Radiotherapy Drug Business (2020-2025) & (US$ Million)

Table 56. Bayer Recent Development

Table 57. Endocyte Company Details

Table 58. Endocyte Business Overview

Table 59. Endocyte Targeted Radiotherapy Drug Product

Table 60. Endocyte Revenue in Targeted Radiotherapy Drug Business (2020-2025) & (US$ Million)

Table 61. Endocyte Recent Development

Table 62. Progenics Pharmaceuticals Company Details

Table 63. Progenics Pharmaceuticals Business Overview

Table 64. Progenics Pharmaceuticals Targeted Radiotherapy Drug Product

Table 65. Progenics Pharmaceuticals Revenue in Targeted Radiotherapy Drug Business (2020-2025) & (US$ Million)

Table 66. Progenics Pharmaceuticals Recent Development

Table 67. Jubilant Radiopharma Company Details

Table 68. Jubilant Radiopharma Business Overview

Table 69. Jubilant Radiopharma Targeted Radiotherapy Drug Product

Table 70. Jubilant Radiopharma Revenue in Targeted Radiotherapy Drug Business (2020-2025) & (US$ Million)

Table 71. Jubilant Radiopharma Recent Development

Table 72. Curium Company Details

Table 73. Curium Business Overview

Table 74. Curium Targeted Radiotherapy Drug Product

Table 75. Curium Revenue in Targeted Radiotherapy Drug Business (2020-2025) & (US$ Million)

Table 76. Curium Recent Development

Table 77. Fermi Energia Company Details

Table 78. Fermi Energia Business Overview

Table 79. Fermi Energia Targeted Radiotherapy Drug Product

Table 80. Fermi Energia Revenue in Targeted Radiotherapy Drug Business (2020-2025) & (US$ Million)

Table 81. Fermi Energia Recent Development

Table 82. Nucleus RadioPharma Company Details

Table 83. Nucleus RadioPharma Business Overview

Table 84. Nucleus RadioPharma Targeted Radiotherapy Drug Product

Table 85. Nucleus RadioPharma Revenue in Targeted Radiotherapy Drug Business (2020-2025) & (US$ Million)

Table 86. Nucleus RadioPharma Recent Development

Table 87. Research Programs/Design for This Report

Table 88. Key Data Information from Secondary Sources

Table 89. Key Data Information from Primary Sources

Table 90. Authors List of This Report

List of Figures

Figure 1. Targeted Radiotherapy Drug Picture

Figure 2. Global Targeted Radiotherapy Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Targeted Radiotherapy Drug Market Share by Type: 2024 VS 2031

Figure 4. Radioactive Iodine Therapeutic Drugs Features

Figure 5. Radioactive Antibody Therapeutic Drugs Features

Figure 6. Others Features

Figure 7. Global Targeted Radiotherapy Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Targeted Radiotherapy Drug Market Share by Application: 2024 VS 2031

Figure 9. General Hospital Case Studies

Figure 10. Specialty Hospital Case Studies

Figure 11. Targeted Radiotherapy Drug Report Years Considered

Figure 12. Global Targeted Radiotherapy Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Targeted Radiotherapy Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Targeted Radiotherapy Drug Market Share by Region: 2024 VS 2031

Figure 15. Global Targeted Radiotherapy Drug Market Share by Players in 2024

Figure 16. Global Top Targeted Radiotherapy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radiotherapy Drug as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Targeted Radiotherapy Drug Revenue in 2024

Figure 18. North America Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Targeted Radiotherapy Drug Market Share by Country (2020-2031)

Figure 20. United States Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Targeted Radiotherapy Drug Market Share by Country (2020-2031)

Figure 24. Germany Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Targeted Radiotherapy Drug Market Share by Region (2020-2031)

Figure 32. China Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Targeted Radiotherapy Drug Market Share by Country (2020-2031)

Figure 40. Mexico Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Targeted Radiotherapy Drug Market Share by Country (2020-2031)

Figure 44. Turkey Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Targeted Radiotherapy Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Novartis Revenue Growth Rate in Targeted Radiotherapy Drug Business (2020-2025)

Figure 48. Bayer Revenue Growth Rate in Targeted Radiotherapy Drug Business (2020-2025)

Figure 49. Endocyte Revenue Growth Rate in Targeted Radiotherapy Drug Business (2020-2025)

Figure 50. Progenics Pharmaceuticals Revenue Growth Rate in Targeted Radiotherapy Drug Business (2020-2025)

Figure 51. Jubilant Radiopharma Revenue Growth Rate in Targeted Radiotherapy Drug Business (2020-2025)

Figure 52. Curium Revenue Growth Rate in Targeted Radiotherapy Drug Business (2020-2025)

Figure 53. Fermi Energia Revenue Growth Rate in Targeted Radiotherapy Drug Business (2020-2025)

Figure 54. Nucleus RadioPharma Revenue Growth Rate in Targeted Radiotherapy Drug Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oncology Targeted Therapy Market Research Report 2025

Global Targeted Small Molecule Drug Market Research Report 2025

Global Targeted Small Molecule Therapy Market Research Report 2025

Global Cancer Targeted Small Molecule Therapy Market Research Report 2025

Global Targeted Radiopharmaceuticals Market Research Report 2024

Global Targeted Cancer Therapy Market Research Report 2024

Global Targeted Oncology Drugs Market Research Report 2024

Global Radioactive Therapeutic Drugs Market Research Report 2024

Global Targeted Radionuclide Therapy Market Research Report 2024

Global Targeted Chemotherapy Drugs Market Research Report 2024

Global Personalized Cancer Medicine Market Research Report 2025

Global Systemic Radiotherapy Market Research Report 2024

Global Cancer Radiotherapy Market Research Report 2025

Global Targeted Antitumor Drugs Market Research Report 2025

Global Radiotherapy Market Research Report 2024

Global Radiopharmaceutical Therapy Market Research Report 2025

Targeted Radionuclide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Injectable Targeted Therapy Market Research Report 2024

Global Radioisotopes in Medicine Market Research Report 2025

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions